Literature DB >> 18975499

Neurocognitive impairment in early HIV-positive individuals.

Nikhiles Mandal1, Om Prakash Singh, Subodh Bhattacharya, Subhamay Chatterji, Anirban Biswas, Subrata Sen.   

Abstract

The study was carried out to find out the cognitive impairment if any, in early stages of human immunodeficiency virus-positive patients and if there is any cognitive impairment, then its association with duration of illness detection. Fifty patients with early stages of HIV and 50 matched controls were compared in various neuropsychological tests along with demographic profiles. Seropositive patients had poorly performed in digit symbol substitution test, trail making test and controlled word association test. This impairment had no association with duration of detection of illness. It is not known whether mild neurocognitive disorder predisposes patients to the development of frank dementia. Cognitive impairment should be identified early in order to maximise functional status, enhance quality of life and survival time.

Entities:  

Mesh:

Year:  2008        PMID: 18975499

Source DB:  PubMed          Journal:  J Indian Med Assoc        ISSN: 0019-5847


  4 in total

1.  Management of Psychiatric Disorders with HIV and Dermatological Disorders.

Authors:  Om Prakash Singh; Sujit Sarkhel; Sharmila Sarkar
Journal:  Indian J Psychiatry       Date:  2022-03-23       Impact factor: 2.983

2.  HIV and mental health: An overview of research from India.

Authors:  Nishanth Jayarajan; Prabha S Chandra
Journal:  Indian J Psychiatry       Date:  2010-01       Impact factor: 1.759

3.  [Emotional status, cognitive performance and quality of life in HIV-infected patients. Results of an exploratory study].

Authors:  D Baumschlager; A Haas-Krammer; H-B Rothenhäusler
Journal:  Nervenarzt       Date:  2011-07       Impact factor: 1.214

4.  Study to assess the prevalence, nature and extent of cognitive impairment in people living with AIDS.

Authors:  Karthigaipriya Muniyandi; J Venkatesan; T Arutselvi; V Jayaseelan
Journal:  Indian J Psychiatry       Date:  2012-04       Impact factor: 1.759

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.